Influenza B is a serious infection that can cause the same range of complications as influenza A, including pneumonia, seizures, and hospitalization. While flu A tends to dominate headlines and cause more total cases each season, flu B is not a milder version of the flu. Studies comparing hospitalized patients with either type have found no significant difference in clinical severity, ICU admissions, or length of hospital stay.
How Flu B Compares to Flu A in Severity
The assumption that flu B is the “mild” flu doesn’t hold up in clinical data. A study of 391 children hospitalized with influenza found no meaningful differences in outcomes between the two types. Children with flu A and flu B had similar rates of ICU treatment, similar hospital stays, and similar rates of the most severe complications. The researchers concluded that the clinical severity of influenza A and B infections is comparable in children.
Flu A does cause more total deaths and hospitalizations each season, but that’s largely because it infects more people overall, not because each individual case is worse. In nearly every flu season since the CDC began tracking pediatric deaths, influenza A has been associated with more deaths than influenza B simply because A accounts for the majority of circulating virus. Out of 280 pediatric flu deaths analyzed across recent seasons, 86% were linked to flu A and 14% to flu B, roughly in proportion to how many cases each type causes.
Complications That Make Flu B Dangerous
Flu B can trigger the same life-threatening complications as flu A. Among children who died from influenza (either type), the most common complications before death were shock or sepsis (50%), pneumonia (38%), acute respiratory distress syndrome (28%), seizures (24%), and brain swelling or inflammation (18%).
One area where flu B may actually pose a distinct risk is neurological complications. A study of adults hospitalized with confirmed flu B in Romania found that some patients developed encephalitis (brain inflammation) or cerebellar ataxia (loss of coordination) as their primary complication, not pneumonia. Two of the seven patients with neurological complications died, and notably, their deaths were caused by the brain involvement rather than respiratory failure. The mortality rate among flu B patients with neurological complications reached 28.5% in that study, compared to 9.3% for all hospitalized flu B patients at the same facility.
Who Flu B Hits Hardest
Flu B tends to circulate more heavily among children and adolescents than among older adults. This pattern means school-age kids are often the group most affected during B-dominant seasons. Young children, older adults, pregnant individuals, and people with chronic health conditions like asthma, diabetes, or heart disease remain at highest risk for severe outcomes from either flu type.
How Long Flu B Lasts
The timeline is essentially the same as flu A. After exposure, symptoms typically appear in about two days, though the incubation period can range from one to four days. You’re most contagious during the first three days of illness. Most healthy people recover within one to two weeks, though fatigue and cough can linger. The acute phase, with fever, body aches, sore throat, and exhaustion, usually peaks within the first few days and begins improving by day five to seven.
Treatment Responds Differently to Flu B
Here’s something most people don’t realize: the most commonly prescribed antiviral for flu may work less effectively against type B. Oseltamivir (the generic name for Tamiflu) requires a higher concentration to inhibit flu B compared to flu A, and studies have found it has lower clinical effectiveness in infants and children with flu B specifically.
A newer antiviral, baloxavir (Xofluza), appears to reduce viral levels faster and may be more effective at preventing hospitalization in flu B patients. One study comparing the two drugs found that baloxavir showed a greater advantage over oseltamivir in flu B cases than in flu A cases. If you’re diagnosed with flu B, it’s worth knowing that treatment options exist beyond the standard prescription, particularly if symptoms are severe or you’re in a high-risk group.
Testing Can Miss Flu B
Rapid flu tests, the kind you get results from in 15 to 20 minutes at a clinic, have a sensitivity of roughly 50 to 70% compared to more accurate PCR lab tests. That means a negative rapid test doesn’t rule out the flu. False negatives are common, especially during peak flu season. The FDA now requires newer rapid tests to achieve at least 80% sensitivity, but older tests still in use may fall short. If your rapid test comes back negative but you have classic flu symptoms during an active flu season, a PCR test can provide a definitive answer.
Only One Flu B Lineage Remains
Influenza B has historically split into two lineages: Victoria and Yamagata. The Yamagata lineage appears to have gone extinct or nearly so following the COVID-19 pandemic. It hasn’t been reliably detected in circulation since March 2020, and the rare detections since then are likely from vaccine-derived virus or data errors. This has prompted health authorities to consider switching flu vaccines from four-strain (quadrivalent) formulations back to three-strain (trivalent) versions that drop the Yamagata component. The remaining Victoria lineage continues to circulate and cause seasonal outbreaks. Recent vaccine effectiveness against flu B Victoria has been estimated around 72% in some seasons, though this varies year to year depending on how well the vaccine strain matches what’s actually circulating.